A team of UF researchers has identified dozens of novel therapeutic targets for the development of antiviral therapies against COVID-19 and other coronaviruses that infect people.
A UF team of infectious disease experts propose a core protocol for such vaccination trials.
The COVID-19 pandemic has drawn attention to the importance of the historical record of infectious disease and the importance of cultural practices, then and now.
As the new vaccines developed to combat COVID-19 begin to flow into communities around the country, myths and misinformation are coursing through the general population as well.
Lisa Merlo Greene, director of wellness programs at the University of Florida College of Medicine, offers tools to maintain wellness during a time of uncertainty.
Telemedicine became standard practice, even though it was rarely used before the pandemic.
John Smulian, chair of the UF College of Medicine’s department of obstetrics and gynecology, provides important information on what is known about the novel coronavirus and pregnancy.
A new University of Florida epidemiological study finds that while children are less susceptible to COVID-19, when they do become infected they can be nearly 60% more likely than adults over 60 to infect exposed family members.
A wristband that tells kids when they’re too close together at school. A wearable that detects a possible COVID infection before you feel sick.
The leading COVID-19 vaccines aren’t anything like the polio vaccination your grandparents received — or even the flu shot you got this fall.
The mortality rate of the COVID-19 pandemic has altered the standard process of drug development, amplifying the need for lifesaving treatment and marking the start of the sprint toward a cure or gold standard treatment.
In recent years, public health emergencies caused by epidemics have led to the use of genome sequencing to identify and characterize viral pathogens.